Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Characterization of Wood Derived Hierarchical Cellulose Scaffolds for Multifunctional Applications.

Segmehl JS, Studer V, Keplinger T, Burgert I.

Materials (Basel). 2018 Mar 28;11(4). pii: E517. doi: 10.3390/ma11040517.

2.

Treadmill Training with Cues and Feedback Improves Gait in People with More Advanced Parkinson's Disease.

Studer V, Maestri R, Clerici I, Spina L, Zivi I, Ferrazzoli D, Frazzitta G.

J Parkinsons Dis. 2017;7(4):729-739. doi: 10.3233/JPD-171126.

PMID:
29103048
3.

Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis.

Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, Giovannetti AM, Pareja-Gutierrez L, Calò A, Colonna I, Furlan R, Martino G, Centonze D.

Neurology. 2017 Sep 26;89(13):1338-1347. doi: 10.1212/WNL.0000000000004411. Epub 2017 Aug 25.

PMID:
28842450
4.

Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability.

Studer V, Rocchi C, Motta C, Lauretti B, Perugini J, Brambilla L, Pareja-Gutierrez L, Camera G, Barbieri FR, Marfia GA, Centonze D, Rossi S.

Mult Scler J Exp Transl Clin. 2017 Apr 5;3(2):2055217317701317. doi: 10.1177/2055217317701317. eCollection 2017 Apr-Jun.

5.

3D Protein Dynamics in the Cell Nucleus.

Singh AP, Galland R, Finch-Edmondson ML, Grenci G, Sibarita JB, Studer V, Viasnoff V, Saunders TE.

Biophys J. 2017 Jan 10;112(1):133-142. doi: 10.1016/j.bpj.2016.11.3196.

6.

Quantification of postural stability in minimally disabled multiple sclerosis patients by means of dynamic posturography: an observational study.

Grassi L, Rossi S, Studer V, Vasco G, Motta C, Patanè F, Castelli E, Rossi S, Cappa P.

J Neuroeng Rehabil. 2017 Jan 10;14(1):4. doi: 10.1186/s12984-016-0216-8.

7.

How cells respond to environmental cues - insights from bio-functionalized substrates.

Ruprecht V, Monzo P, Ravasio A, Yue Z, Makhija E, Strale PO, Gauthier N, Shivashankar GV, Studer V, Albiges-Rizo C, Viasnoff V.

J Cell Sci. 2017 Jan 1;130(1):51-61. doi: 10.1242/jcs.196162. Epub 2016 Nov 17. Review.

8.

Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes.

Bacigaluppi M, Russo GL, Peruzzotti-Jametti L, Rossi S, Sandrone S, Butti E, De Ceglia R, Bergamaschi A, Motta C, Gallizioli M, Studer V, Colombo E, Farina C, Comi G, Politi LS, Muzio L, Villani C, Invernizzi RW, Hermann DM, Centonze D, Martino G.

J Neurosci. 2016 Oct 12;36(41):10529-10544.

9.

Targeting New Pharmacological Approaches for Alzheimer's Disease: Potential for Statins and Phosphodiesterase Inhibitors.

Sallustio F, Studer V.

CNS Neurol Disord Drug Targets. 2016;15(6):647-59. Review.

PMID:
27189469
10.

Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.

Motta C, Palermo E, Studer V, Germanotta M, Germani G, Centonze D, Cappa P, Rossi S, Rossi S.

PLoS One. 2016 Feb 10;11(2):e0148997. doi: 10.1371/journal.pone.0148997. eCollection 2016.

11.

Activation of the cAMP/protein kinase A signalling pathway by coronin 1 is regulated by cyclin-dependent kinase 5 activity.

Liu X, BoseDasgupta S, Jayachandran R, Studer V, Rühl S, Stiess M, Pieters J.

FEBS Lett. 2016 Jan;590(2):279-87. doi: 10.1002/1873-3468.12046. Epub 2016 Jan 20.

12.

Multiprotein Printing by Light-Induced Molecular Adsorption.

Strale PO, Azioune A, Bugnicourt G, Lecomte Y, Chahid M, Studer V.

Adv Mater. 2016 Mar 9;28(10):2024-9. doi: 10.1002/adma.201504154. Epub 2015 Dec 21.

PMID:
26689426
13.

3D high- and super-resolution imaging using single-objective SPIM.

Galland R, Grenci G, Aravind A, Viasnoff V, Studer V, Sibarita JB.

Nat Methods. 2015 Jul;12(7):641-4. doi: 10.1038/nmeth.3402. Epub 2015 May 11.

PMID:
25961414
14.

Subrepellent doses of Slit1 promote Netrin-1 chemotactic responses in subsets of axons.

Dupin I, Lokmane L, Dahan M, Garel S, Studer V.

Neural Dev. 2015 Mar 20;10:5. doi: 10.1186/s13064-015-0036-8.

15.

Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment.

Rossi S, Studer V, Motta C, Centonze D.

J Neurol Sci. 2015 Mar 15;350(1-2):101-2. doi: 10.1016/j.jns.2015.01.023. Epub 2015 Jan 28. No abstract available.

PMID:
25676590
16.

Subclinical central inflammation is risk for RIS and CIS conversion to MS.

Rossi S, Motta C, Studer V, Macchiarulo G, Germani G, Finardi A, Furlan R, Martino G, Centonze D.

Mult Scler. 2015 Oct;21(11):1443-52. doi: 10.1177/1352458514564482. Epub 2015 Jan 12.

PMID:
25583841
17.

Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.

Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, Weiss S, Battistini L, Martino G, Furlan R, Drulovic J, Centonze D.

Mol Neurodegener. 2014 Dec 12;9:56. doi: 10.1186/1750-1326-9-56.

18.

Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis.

Studer V, Rossi S, Motta C, Buttari F, Centonze D.

J Neuroimmunol. 2014 Nov 15;276(1-2):229-31. doi: 10.1016/j.jneuroim.2014.08.617. Epub 2014 Aug 19.

PMID:
25175066
19.

The autonomic balance predicts cardiac responses after the first dose of fingolimod.

Rossi S, Rocchi C, Studer V, Motta C, Lauretti B, Germani G, Macchiarulo G, Marfia GA, Centonze D.

Mult Scler. 2015 Feb;21(2):206-16. doi: 10.1177/1352458514538885. Epub 2014 Jun 23.

PMID:
24957049
20.

Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.

Rossi S, Motta C, Studer V, Rocchi C, Macchiarulo G, Barbieri F, Marfia G, Furlan R, Martino G, Mancino R, Centonze D.

Mult Scler. 2014 Dec;20(14):1841-50. doi: 10.1177/1352458514537365. Epub 2014 May 29.

PMID:
24876157
21.

Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids.

Rossi S, Motta C, Studer V, Boffa L, De Chiara V, Castelli M, Barbieri F, Buttari F, Monteleone F, Germani G, Macchiarulo G, Weiss S, Centonze D.

CNS Neurosci Ther. 2014 Aug;20(8):748-53. doi: 10.1111/cns.12282. Epub 2014 May 19.

PMID:
24837039
22.

Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis.

Mori F, Nicoletti CG, Rossi S, Motta C, Kusayanagi H, Bergami A, Studer V, Buttari F, Barbieri F, Weiss S, Nisticò R, Martino G, Furlan R, Centonze D.

Neuromolecular Med. 2014 Jun;16(2):490-8. doi: 10.1007/s12017-014-8297-7. Epub 2014 Mar 27.

PMID:
24671722
23.

Coronin 1 regulates cognition and behavior through modulation of cAMP/protein kinase A signaling.

Jayachandran R, Liu X, Bosedasgupta S, Müller P, Zhang CL, Moshous D, Studer V, Schneider J, Genoud C, Fossoud C, Gambino F, Khelfaoui M, Müller C, Bartholdi D, Rossez H, Stiess M, Houbaert X, Jaussi R, Frey D, Kammerer RA, Deupi X, de Villartay JP, Lüthi A, Humeau Y, Pieters J.

PLoS Biol. 2014 Mar 25;12(3):e1001820. doi: 10.1371/journal.pbio.1001820. eCollection 2014 Mar.

24.

Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis.

Rossi S, Studer V, Motta C, Germani G, Macchiarulo G, Buttari F, Mancino R, Castelli M, De Chiara V, Weiss S, Martino G, Furlan R, Centonze D.

J Neuroinflammation. 2014 Feb 18;11:32. doi: 10.1186/1742-2094-11-32.

25.

Initiation of multicellular differentiation in Dictyostelium discoideum is regulated by coronin A.

Vinet AF, Fiedler T, Studer V, Froquet R, Dardel A, Cosson P, Pieters J.

Mol Biol Cell. 2014 Mar;25(5):688-701. doi: 10.1091/mbc.E13-04-0219. Epub 2014 Jan 8.

26.

Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis.

Rossi S, Bozzali M, Bari M, Mori F, Studer V, Motta C, Buttari F, Cercignani M, Gravina P, Mastrangelo N, Castelli M, Mancino R, Nucci C, Sottile F, Bernardini S, Maccarrone M, Centonze D.

PLoS One. 2013 Dec 31;8(12):e82848. doi: 10.1371/journal.pone.0082848. eCollection 2013.

27.

Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis.

Mori F, Rossi S, Piccinin S, Motta C, Mango D, Kusayanagi H, Bergami A, Studer V, Nicoletti CG, Buttari F, Barbieri F, Mercuri NB, Martino G, Furlan R, Nisticò R, Centonze D.

J Neurosci. 2013 Dec 4;33(49):19112-9. doi: 10.1523/JNEUROSCI.2536-13.2013.

28.

Investigating axonal guidance with microdevice-based approaches.

Dupin I, Dahan M, Studer V.

J Neurosci. 2013 Nov 6;33(45):17647-55. doi: 10.1523/JNEUROSCI.3277-13.2013. Review.

29.

Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.

Musella A, Mandolesi G, Gentile A, Rossi S, Studer V, Motta C, Sepman H, Fresegna D, Haji N, Paolillo A, Matarese G, Centonze D.

J Neuroimmunol. 2013 Nov 15;264(1-2):8-13. doi: 10.1016/j.jneuroim.2013.08.009. Epub 2013 Aug 31.

PMID:
24045165
30.

Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.

Rossi S, Motta C, Studer V, Barbieri F, Buttari F, Bergami A, Sancesario G, Bernardini S, De Angelis G, Martino G, Furlan R, Centonze D.

Mult Scler. 2014 Mar;20(3):304-12. doi: 10.1177/1352458513498128. Epub 2013 Jul 25.

PMID:
23886826
31.

Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum.

De Chiara V, Motta C, Rossi S, Studer V, Barbieri F, Lauro D, Bernardi G, Centonze D.

Neuroscience. 2013 Oct 10;250:232-9. doi: 10.1016/j.neuroscience.2013.06.069. Epub 2013 Jul 12.

PMID:
23856068
32.

Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.

Rossi S, Studer V, Moscatelli A, Motta C, Coghe G, Fenu G, Caillier S, Buttari F, Mori F, Barbieri F, Castelli M, De Chiara V, Monteleone F, Mancino R, Bernardi G, Baranzini SE, Marrosu MG, Oksenberg JR, Centonze D.

PLoS One. 2013 Jun 28;8(6):e67357. doi: 10.1371/journal.pone.0067357. Print 2013.

33.

Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.

Gentile A, Rossi S, Studer V, Motta C, De Chiara V, Musella A, Sepman H, Fresegna D, Musumeci G, Grasselli G, Haji N, Weiss S, Hayardeny L, Mandolesi G, Centonze D.

J Neuroimmune Pharmacol. 2013 Jun;8(3):651-63. doi: 10.1007/s11481-013-9436-x. Epub 2013 Jan 31.

PMID:
23370991
34.

Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.

Ruffini F, Rossi S, Bergamaschi A, Brambilla E, Finardi A, Motta C, Studer V, Barbieri F, De Chiara V, Hayardeny L, Comi G, Centonze D, Martino G.

Mult Scler. 2013 Jul;19(8):1084-94. doi: 10.1177/1352458512469698. Epub 2012 Dec 11.

PMID:
23232603
35.

Amplification and temporal filtering during gradient sensing by nerve growth cones probed with a microfluidic assay.

Morel M, Shynkar V, Galas JC, Dupin I, Bouzigues C, Studer V, Dahan M.

Biophys J. 2012 Oct 17;103(8):1648-56. doi: 10.1016/j.bpj.2012.08.040. Epub 2012 Oct 16.

36.

Interleukin-1β causes anxiety by interacting with the endocannabinoid system.

Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D.

J Neurosci. 2012 Oct 3;32(40):13896-905. doi: 10.1523/JNEUROSCI.1515-12.2012.

37.

Engineering the surface properties of microfluidic stickers.

Levaché B, Azioune A, Bourrel M, Studer V, Bartolo D.

Lab Chip. 2012 Sep 7;12(17):3028-31. doi: 10.1039/c2lc40284j.

PMID:
22855124
38.

TNF-α-mediated anxiety in a mouse model of multiple sclerosis.

Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, Musella A, Sepman H, Motta C, Studer V, De Chiara V, Bernardi G, Strata P, Centonze D.

Exp Neurol. 2012 Oct;237(2):296-303. doi: 10.1016/j.expneurol.2012.07.010. Epub 2012 Jul 24.

PMID:
22836148
39.

Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.

Rossi S, Motta C, Studer V, De Chiara V, Barbieri F, Monteleone F, Fornasiero A, Coarelli G, Bernardi G, Cutter G, Stüve O, Salvetti M, Centonze D.

Eur J Neurol. 2013 Jan;20(1):87-94. doi: 10.1111/j.1468-1331.2012.03794.x. Epub 2012 Jun 28.

PMID:
22741530
40.

Compressive fluorescence microscopy for biological and hyperspectral imaging.

Studer V, Bobin J, Chahid M, Mousavi HS, Candes E, Dahan M.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1679-87. doi: 10.1073/pnas.1119511109. Epub 2012 Jun 11.

41.

A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation.

Rossi S, Motta C, Studer V, Monteleone F, De Chiara V, Buttari F, Barbieri F, Bernardi G, Battistini L, Cutter G, Stüve O, Salvetti M, Centonze D.

Mult Scler. 2013 Jan;19(1):59-68. doi: 10.1177/1352458512448106. Epub 2012 May 10.

PMID:
22577119
42.

Inflammation inhibits GABA transmission in multiple sclerosis.

Rossi S, Studer V, Motta C, De Chiara V, Barbieri F, Bernardi G, Centonze D.

Mult Scler. 2012 Nov;18(11):1633-5. doi: 10.1177/1352458512440207. Epub 2012 Mar 14.

PMID:
22419673
43.

Concentration landscape generators for shear free dynamic chemical stimulation.

Morel M, Galas JC, Dahan M, Studer V.

Lab Chip. 2012 Apr 7;12(7):1340-6. doi: 10.1039/c2lc20994b. Epub 2012 Feb 20.

PMID:
22344388
44.

Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.

Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, Musella A, Bergami A, Muzio L, Bernardi G, Battistini L, Martino G, Centonze D.

Ann Neurol. 2012 Jan;71(1):76-83. doi: 10.1002/ana.22512.

PMID:
22275254
45.

Hypoxia-inducible factor 1 controls the expression of the uncoordinated-5-B receptor, but not of netrin-1, in first trimester human placenta.

Dakouane-Giudicelli M, Alfaidy N, Bayle P, Tassin de Nonneville A, Studer V, Rozenberg P, de Mazancourt P.

Int J Dev Biol. 2011;55(10-12):981-7. doi: 10.1387/ijdb.103276md.

46.

Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.

Castelli M, Federici M, Rossi S, De Chiara V, Napolitano F, Studer V, Motta C, Sacchetti L, Romano R, Musella A, Bernardi G, Siracusano A, Gu HH, Mercuri NB, Usiello A, Centonze D.

Eur J Neurosci. 2011 Nov;34(9):1369-77. doi: 10.1111/j.1460-9568.2011.07876.x.

PMID:
22034972
47.

Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.

Rossi S, Lo Giudice T, De Chiara V, Musella A, Studer V, Motta C, Bernardi G, Martino G, Furlan R, Martorana A, Centonze D.

Br J Pharmacol. 2012 Feb;165(4):861-9. doi: 10.1111/j.1476-5381.2011.01579.x.

48.

Photopatterning of ultrathin electrochemiluminescent redox hydrogel films.

Milutinovic M, Suraniti E, Studer V, Mano N, Manojlovic D, Sojic N.

Chem Commun (Camb). 2011 Aug 28;47(32):9125-7. doi: 10.1039/c1cc12724a. Epub 2011 Jul 8.

PMID:
21738936
49.

Analysis of gene expression at the single-cell level using microdroplet-based microfluidic technology.

Mary P, Dauphinot L, Bois N, Potier MC, Studer V, Tabeling P.

Biomicrofluidics. 2011 Jun;5(2):24109. doi: 10.1063/1.3596394. Epub 2011 Jun 3.

50.

Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.

Rossi S, Mancino R, Bergami A, Mori F, Castelli M, De Chiara V, Studer V, Mataluni G, Sancesario G, Parisi V, Kusayanagi H, Bernardi G, Nucci C, Bernardini S, Martino G, Furlan R, Centonze D.

Mult Scler. 2011 Nov;17(11):1301-12. doi: 10.1177/1352458511410342. Epub 2011 Jun 15.

PMID:
21677024

Supplemental Content

Loading ...
Support Center